Calidi Biotherapeutics (CLDI) Gains from Investment Securities (2022 - 2025)
Calidi Biotherapeutics' quarterly Gains from Investment Securities came in at $17000.0 in Q4 2025, up 325.0% year-on-year from $4000.0 in Q4 2024, and down 92.17% quarter-over-quarter from $217000.0 in Q3 2025.
Calidi Biotherapeutics has reported Gains from Investment Securities for 4 years, with the latest figure at $17000.0 in Q4 2025.
- For the quarter ending Q4 2025, Gains from Investment Securities rose 325.0% year-over-year to $17000.0; the trailing twelve-month figure through Dec 2025 stood at $17000.0 (down 98.66% YoY), and the FY2025 full-year result was $17000.0, down 77.92% from the prior year.
- Gains from Investment Securities for Q4 2025 stood at $17000.0, down from $217000.0 in the prior quarter.
- The five-year high for Gains from Investment Securities was $7.6 million in Q2 2024, with the low at -$6.7 million in Q4 2022.
- Average Gains from Investment Securities over 4 years is -$27387.8, with a median of $17000.0 recorded in 2025.
- Year-over-year, Gains from Investment Securities jumped 860.87% in 2023 and slumped 98.28% in 2025.
- Tracing CLDI's Gains from Investment Securities over 4 years: stood at -$6.7 million in 2022, then jumped by 152.28% to $3.5 million in 2023, then slumped by 99.89% to $4000.0 in 2024, then jumped by 325.0% to $17000.0 in 2025.
- The last three Gains from Investment Securities figures came in at $17000.0 (Q4 2025), $217000.0 (Q3 2025), and $131000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn |
| 10 | Calidi Biotherapeutics | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 17,000.00 |
| Dec 31, 2025 | 17,000.00 |
| Sep 30, 2025 | 217,000.00 |
| Sep 30, 2025 | 217,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Jun 30, 2025 | 131,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Dec 31, 2024 | 4,000.00 |
| Sep 30, 2024 | 90,000.00 |
| Sep 30, 2024 | 90,000.00 |
| Jun 30, 2024 | 7.60 Mn |
| Jun 30, 2024 | 7.60 Mn |
| Mar 31, 2024 | 40,000.00 |
| Mar 31, 2024 | 40,000.00 |
| Sep 30, 2023 | 3.50 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | -14,000.00 |
| Mar 31, 2023 | -14,000.00 |
| Dec 31, 2022 | -6.69 Mn |
| Dec 31, 2022 | -6.69 Mn |
| Sep 30, 2022 | -460,000.00 |
| Sep 30, 2022 | -460,000.00 |
| Jun 30, 2022 | -4.03 Mn |
| Jun 30, 2022 | -4.03 Mn |
| Mar 31, 2022 | -2.09 Mn |
| Mar 31, 2022 | -2.09 Mn |